FCM
ALBO

Farallon Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Farallon Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-250,000
Closed -$8.79M – 318
2021
Q2 		$8.79M Hold
250,000
– – 0.04% 139
2021
Q1 		$8.81M Hold
250,000
– – 0.04% 149
2020
Q4 		$9.38M Buy
250,000
+50,000
+25% +$1.82M 0.06% 109
2020
Q3 		$6.67M Buy
+200,000
New +$5.83M 0.05% 105

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Farallon Capital Management's ALBO Position: Q3 2021 in Review

Farallon Capital Management sold out of Albireo Pharma Inc (ALBO) in Q3 2021, closing a stake of 250,000 shares — an estimated $8.79M sold.

Farallon Capital Management first reported a position in ALBO in Q3 2020 and held it in 4 quarters. The position peaked at $9.38M in Q4 2020. 94 funds tracked by Wall St. Rank hold ALBO as of Q3 2021.

  • Farallon Capital Management reported no remaining Albireo Pharma Inc position as of Q3 2021 after selling out during the quarter.
  • Farallon Capital Management sold 250,000 Albireo Pharma Inc shares in Q3 2021, an estimated $8.79M.
  • Farallon Capital Management first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 4 quarters.
  • Farallon Capital Management's Albireo Pharma Inc position peaked at $9.38M in Q4 2020.
  • 94 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2021.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.